Acquisition of Apexigen (Tables)

12 Months Ended

Dec. 31, 2024

Business Combinations [Abstract]

Summary of Purchase Price Allocated to The Assets Acquired and Liabilities Assumed

The purchase price was allocated to the assets acquired and liabilities assumed on August 23, 2023, based on their estimated fair value, summarized below (in thousands):

	Amount
Assets acquired:
Cash and cash equivalents	$	6,660
Prepaid expenses and other current assets		519
Intangible assets, net		24,458
Total identifiable assets	$	31,637
Liabilities assumed:
Accounts payable		(4,548	)
Accrued liabilities		(7,531	)
Deferred tax liability, net		(2,164	)
Deferred revenue		(6,662	)
Total identifiable liabilities		(20,905	)
Total purchase price	$	10,732